Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 21,035 | 3,646 | 51,967 | 39,512 | 26,499 |
| Operating Income | -21,035 | -3,646 | -51,967 | -39,512 | -26,499 |
| Interest Expense | 34 | 4 | 2,180 | 1,204 | 817 |
| Other Income | 13,688 | -187 | 701 | 49 | -1,871 |
| Pre-tax Income | -7,380 | -3,837 | -53,446 | -40,667 | -29,186 |
| Income Tax | -382 | N/A | -2,586 | -1,846 | -1,107 |
| Net Income Continuous | -6,999 | -3,837 | -50,860 | -38,821 | -28,079 |
| Net Income | $-6,999 | $-3,837 | $-50,860 | $-38,821 | $-28,079 |
| EPS Basic Total Ops | -1.44 | -1.15 | -33.40 | -26.80 | -80.20 |
| EPS Basic Continuous Ops | -1.44 | -1.15 | -33.47 | -26.90 | -69.43 |
| EPS Diluted Total Ops | -1.44 | -1.15 | -33.40 | -26.80 | -80.20 |
| EPS Diluted Continuous Ops | -1.44 | -1.15 | -33.47 | -26.90 | -69.43 |
| EPS Diluted Before Non-Recurring Items | -3.57 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,936 | $-3,577 | $-51,642 | $-39,246 | $-26,247 |